Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Dec 18, 2009	YANCOPOULOS GEORGE Director, EVP CSO & Pres Regn Res Labs	Director, EVP CSO & Pres Regn Res Labs	Form 4	Grant, award or other acquisition pursuant to Rule 16b-3(d)	95,295	--	95,295
Dec 15, 2016	YANCOPOULOS GEORGE Director, President Regeneron Laboratori	Director, President Regeneron Laboratori	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	95,223	$380.09	591,348
Dec 13, 2017	YANCOPOULOS GEORGE Director, President & CSO	Director, President & CSO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	95,050	$385.08	680,612
Feb 11, 2014	YANCOPOULOS GEORGE Director, President Regeneron Laboratori	Director, President Regeneron Laboratori	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	94,756	$314.31	1,157,330
Nov 30, 2011	YANCOPOULOS GEORGE Director, EVP CSO President Regeneron Re	Director, EVP CSO President Regeneron Re	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	94,551	$58.19	971,584
Dec 13, 2018	YANCOPOULOS GEORGE Director, President and Chief Scientific	Director, President and Chief Scientific	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	94,048	$16.80	167,185
Dec 13, 2018	YANCOPOULOS GEORGE Director, President and Chief Scientific	Director, President and Chief Scientific	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	94,048	--	--
Dec 17, 2008	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Grant, award or other acquisition pursuant to Rule 16b-3(d)	94,048	--	94,048
May 06, 2013	YANCOPOULOS GEORGE Director, President Regeneron Laboratori	Director, President Regeneron Laboratori	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	93,644	$260.44	1,206,395
Oct 30, 2015	YANCOPOULOS GEORGE Director, President Regeneron Laboratori	Director, President Regeneron Laboratori	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	92,316	$559.08	586,696

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media